Get the Stockscreener App
2.71
1.81%
-0.05
Liminatus Pharma Inc stock is traded at $2.71, with a volume of 381.73K.
It is down -1.81% in the last 24 hours and down -59.49% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$2.76
Open:
$2.7
24h Volume:
381.73K
Relative Volume:
0.32
Market Cap:
$70.50M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-20.53%
1M Performance:
-59.49%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.61
$2.784
1-Week Range:
$2.61
$3.5998
52-Week Range:
$2.53
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
2.71 | 74.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Is Liminatus Pharma Inc. meeting your algorithmic filter criteria2025 Price Targets & Weekly Stock Breakout Alerts - Newser
Will a bounce in Liminatus Pharma Inc. Equity Warrant offer an exitQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Published on: 2025-08-31 03:48:04 - Newser
Liminatus Pharma Inc. Hits Price Floor — Bounce IncomingJuly 2025 EndofMonth & Fast Entry Momentum Trade Alerts - beatles.ru
Published on: 2025-08-31 01:29:24 - Newser
Liminatus gains amid review to consider digital assets for treasury management - MSN
What technical models suggest about Liminatus Pharma Inc. Equity Warrant’s comebackJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
What to do if you’re stuck in Liminatus Pharma Inc.Weekly Stock Analysis & AI Optimized Trading Strategy Guides - Newser
What institutional flow reveals about Liminatus Pharma Inc. Equity WarrantJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Does Liminatus Pharma Inc. Equity Warrant fit your quant trading modelPortfolio Profit Report & Short-Term Trading Opportunity Alerts - Newser
Automated trading signals detected on Liminatus Pharma Inc. Equity WarrantIPO Watch & Advanced Swing Trade Entry Plans - Newser
Analyzing recovery setups for Liminatus Pharma Inc. investorsPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Price action breakdown for Liminatus Pharma Inc.Market Risk Summary & Entry Point Strategy Guides - Newser
Why Liminatus Pharma Inc. Equity Warrant is moving todayMarket Trend Report & Community Verified Watchlist Alerts - Newser
How to interpret RSI for Liminatus Pharma Inc. stockAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Can Liminatus Pharma Inc. Equity Warrant hit a new high this monthWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Ranking Liminatus Pharma Inc. among high performing stocks via toolsPortfolio Update Report & Stepwise Trade Signal Guides - Newser
Predicting Liminatus Pharma Inc. Equity Warrant trend using moving averages2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Is it too late to sell Liminatus Pharma Inc.Weekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
How to integrate Liminatus Pharma Inc. Equity Warrant into portfolio analysis tools2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Tools to assess Liminatus Pharma Inc.’s risk profilePortfolio Return Summary & Precise Buy Zone Tips - Newser
News impact scoring models applied to Liminatus Pharma Inc. Equity Warrant2025 Short Interest & Reliable Price Action Trade Plans - Newser
Pattern recognition hints at Liminatus Pharma Inc. upside2025 Trading Recap & Reliable Breakout Forecasts - Newser
Forecasting Liminatus Pharma Inc. price range with options data2025 Earnings Surprises & High Accuracy Investment Entry Signals - Newser
Using data filters to optimize entry into Liminatus Pharma Inc.2025 Momentum Check & Free Community Supported Trade Ideas - Newser
Can a trend reversal in Liminatus Pharma Inc. lead to recoveryJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Will Liminatus Pharma Inc. Equity Warrant price bounce be sustainableJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
Real time pattern detection on Liminatus Pharma Inc. stockJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Liminatus Pharma Inc. Equity Warrant stock retracement – recovery analysisJuly 2025 Momentum & Consistent Profit Alerts - Newser
Will Liminatus Pharma Inc. Equity Warrant see short term momentumJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
What Fibonacci levels say about Liminatus Pharma Inc. Equity Warrant reboundJuly 2025 Movers & Reliable Entry Point Alerts - Newser
Liminatus Pharma Inc. stock volume spike explainedJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
Using economic indicators to assess Liminatus Pharma Inc. Equity Warrant potentialQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Liminatus Pharma Inc Stock (LIMN) Financials Data
There is no financial data for Liminatus Pharma Inc (LIMN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):